HIV type 1 drug resistance patterns among patients failing first and second line antiretroviral therapy in Nairobi, Kenya

[1]  T. F. Rinke de Wit,et al.  HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study , 2014, AIDS Research and Therapy.

[2]  Simon A. A. Travers,et al.  Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens , 2013, PloS one.

[3]  J. Schapiro,et al.  Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries. , 2013, The Journal of infectious diseases.

[4]  M. Holodniy,et al.  Health-related Quality of Life Assessment after Antiretroviral Therapy: A Review of the Literature , 2013, Drugs.

[5]  A. Muigai,et al.  Circulating trends of non-B HIV type 1 subtypes among Kenyan individuals. , 2012, AIDS research and human retroviruses.

[6]  A. Muigai,et al.  HIV Type 1 genetic diversity and naturally occurring polymorphisms in HIV type 1 Kenyan isolates: implications for integrase inhibitors. , 2012, AIDS research and human retroviruses.

[7]  R. Turner,et al.  A randomized trial of the efficacy of hand disinfection for prevention of rhinovirus infection. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  J. Gonzalez,et al.  Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon , 2012, Journal of the International AIDS Society.

[9]  M. Wainberg,et al.  Development of antiretroviral drug resistance. , 2011, The New England journal of medicine.

[10]  R. Lihana,et al.  Genetic characterization of HIV type 1 among patients with suspected immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy in Kenya. , 2010, AIDS research and human retroviruses.

[11]  Ian Sanne,et al.  Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South Africa , 2010, Journal of acquired immune deficiency syndromes.

[12]  W. Stevens,et al.  EMERGENCE OF DRUG RESISTANCE IN HIV-1 SUBTYPE C INFECTED CHILDREN FAILING THE SOUTH AFRICAN NATIONAL ANTIRETROVIRAL ROLL-OUT PROGRAM , 2009, The Pediatric infectious disease journal.

[13]  D. Katzenstein,et al.  Genotypic HIV type-1 drug resistance among patients with immunological failure to first-line antiretroviral therapy in south India , 2009, Antiviral therapy.

[14]  J. Overbaugh,et al.  Lower Risk of Resistance After Short-Course HAART Compared With Zidovudine/Single-Dose Nevirapine Used for Prevention of HIV-1 Mother-to-Child Transmission , 2009, Journal of acquired immune deficiency syndromes.

[15]  P. Reiss,et al.  Immunologic, Virologic, and Clinical Consequences of Episodes of Transient Viremia During Suppressive Combination Antiretroviral Therapy , 2008, Journal of acquired immune deficiency syndromes.

[16]  K. Theys,et al.  Understanding the changing prevalence of K65R. , 2008, AIDS reviews.

[17]  Tara L. Kieffer,et al.  HIV-1 viral load blips are of limited clinical significance. , 2006, The Journal of antimicrobial chemotherapy.

[18]  P. Harrigan,et al.  Adherence–resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness , 2006, AIDS.

[19]  J. Sninsky,et al.  Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC). , 1995, The Journal of infectious diseases.

[20]  M. Peeters,et al.  Antiretroviral drug resistance in HIV-1 infected patients receiving antiretroviral treatment in routine clinics in Cotonou, Benin , 2011 .

[21]  F. Queiroz-Telles,et al.  HIV-1 genotypic resistance profile of patients failing antiretroviral therapy in Paraná, Brazil. , 2010, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.